Clinical Trial Update: A Study of VRN101099 in Patients With HER2-Positive Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for VRN101099 in patients with HER2-positive solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• VRN101099

Snippet

Sponsor: Voronoi, Inc | Conditions: HER2-positive Solid Tumors | Phase 1 | Status: RECRUITING